Linda Palczuk
Direktor/Vorstandsmitglied bei AVADEL PHARMACEUTICALS PLC
Vermögen: 933 768 $ am 30.04.2024
Aktive Positionen von Linda Palczuk
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AVADEL PHARMACEUTICALS PLC | Direktor/Vorstandsmitglied | 01.07.2018 | - |
Independent Dir/Board Member | 01.07.2018 | - | |
Envara Health, Inc.
Envara Health, Inc. Pharmaceuticals: OtherHealth Technology Envara Health, Inc. is a life science and clinical nutrition company based in Malvern, PA. Envara Health is dedicated to addressing the widespread problem of malabsorption and nutritional deficiencies through breakthrough science and clinical evidence. The company's first product, Encala, is a medical food that provides healthy calories, including essential fatty acids, in an easily absorbable structure. Encala has been tested in multiple clinical studies and has been shown to improve the absorption of other fat and nutrients from corresponding meals. Envara Health's validated structured lipid platform is enabling the development of a suite of precision nutrient products that will address a broad spectrum of disease states, in both humans and animals. The company was founded in 2017 by Jim O'Connell and Virginia A. Stallings. Jim O'Connell has been the CEO since 2017. | Geschäftsführer | 01.01.2019 | - |
Karriereverlauf von Linda Palczuk
Ehemalige bekannte Positionen von Linda Palczuk
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VERRICA PHARMACEUTICALS INC. | Geschäftsführer | 01.02.2018 | 22.04.2019 |
OSIRIS THERAPEUTICS, INC. | Vorstandsvorsitzender | 10.07.2017 | 09.02.2018 |
Präsident | 10.07.2017 | 09.02.2018 | |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Vertrieb & Marketing | 01.01.2012 | 01.03.2015 |
Ausbildung von Linda Palczuk
Franklin & Marshall College | Undergraduate Degree |
Alfred Lerner College of Business & Economics | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 7 |
Irland | 2 |
Operativ
Chief Operating Officer | 2 |
Sales & Marketing | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
AVADEL PHARMACEUTICALS PLC | Health Technology |
VERRICA PHARMACEUTICALS INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
Osiris Therapeutics, Inc.
Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
Envara Health, Inc.
Envara Health, Inc. Pharmaceuticals: OtherHealth Technology Envara Health, Inc. is a life science and clinical nutrition company based in Malvern, PA. Envara Health is dedicated to addressing the widespread problem of malabsorption and nutritional deficiencies through breakthrough science and clinical evidence. The company's first product, Encala, is a medical food that provides healthy calories, including essential fatty acids, in an easily absorbable structure. Encala has been tested in multiple clinical studies and has been shown to improve the absorption of other fat and nutrients from corresponding meals. Envara Health's validated structured lipid platform is enabling the development of a suite of precision nutrient products that will address a broad spectrum of disease states, in both humans and animals. The company was founded in 2017 by Jim O'Connell and Virginia A. Stallings. Jim O'Connell has been the CEO since 2017. | Health Technology |
- Börse
- Insiders
- Linda Palczuk
- Erfahrung